Congo to receive 70,000 doses of Ervebo Ebola vaccine which has been effective in past outbreaks

The World Health Organization and partners announced that Congo will receive 70,000 doses of the Ervebo vaccine. The allocation includes 20,000 doses for a Phase 3 clinical trial related to the Bundibugyo virus, with the remaining 50,000 doses intended for front-line workers and health personnel in eastern Congo.